Skip to main content

Table 1 Characteristics and classification of study population

From: Delayed post-diuretic 18F-FDG PET/CT: can it help in determination of the best clinical decision for muscle invasive UB cancer patients?

Age groups

30–39 years

5 [14.2%]

40–49 years

11 [31.4%]

50–59 years

16 [45.7%]

> 59 years

3 [8.5%]

Sex

Male

32 [91.4%]

Female

3 [8.5%]

Pathology

Transitional cell ca.

31 [88.5%]

Squamous cell ca.

4 [11.4%]

Groups

Group A: initial staging

18 [51.4%]

 

Group B: post-therapeutic evaluation

17 (48.6%)